Immunic to participate in industry and investor conferences in september

New york , sept. 6, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and investor conferences in september: september 13-14: biopharm america™.

IMUX Ratings Summary

IMUX Quant Ranking